Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. - Wikidata - wikimedia - TriplyDB

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

http://www.wikidata.org/entity/Q36942534

about

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 The physiology of cardiovascular disease and innovative liposomal platforms for therapy New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis Comparison between Exclusive and Selective Drug-Eluting Stent Strategies in Treating Patients with Multivessel Coronary Artery Disease Drug-eluting stents in patients with chronic kidney disease: a prospective registry study Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study Management standards for stable coronary artery disease in India.Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention Applications of optical coherence tomography in cardiovascular medicine, Part 2 Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?New-Generation Coronary Stents: Current Data and Future Directions.Neurological complications of cardiac surgery.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.Post-approval drug safety surveillance.Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience.Corticosteroid and antiviral therapy for Bell's palsy: a network meta-analysis.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Rapamune does not attenuate high cholesterol-induced atherosclerosis in rabbits.Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions The resolute™ integrity zotarolimus-eluting stent in coronary artery disease: a review.The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life.Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort.Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre Evolution of percutaneous coronary intervention in patients with diabetes: a report from the National Heart, Lung, and Blood Institute-sponsored PTCA (1985-1986) and Dynamic (1997-2006) Registries

P2860

Q24606203-81192F18-61B4-408C-8BC2-0D8146909778 Q26785321-36A5C40B-A598-4261-8F8A-383D2A09CAE2 Q27002949-B2D62395-6CD7-4120-B684-5F045207C2E1 Q27015211-B9310614-4A8E-4985-B215-FB119C5AA08F Q28067509-B65AB1EA-D4CD-4802-AFEC-E033F2ADF995 Q28068387-ECE95C73-05F7-4767-B403-311597F325A7 Q28073031-BCE51D06-0125-49C9-B354-22F9BBB4EAC1 Q28291828-431BAE17-F5BE-42DA-B70C-70F65565D403 Q28468715-FFD4880A-9F8F-4ED6-A212-4F1A4642AE51 Q28476360-817A6F15-DBDA-42DF-A5C8-96B6D1993EE8 Q28533603-ED17CF6F-B724-4346-8810-F0A69E638C94 Q28534994-C43139CD-0A8A-4E5B-8021-832BAFBF0016 Q28545216-F6E96A2C-00DD-49E0-9B23-6E423BC1AF49 Q28545812-7299C2E9-ECE9-4816-BF4D-CD5F95C73871 Q28547354-875F00FE-0300-4FB8-95F1-2D833FBEA3CB Q28547539-92920B19-F182-4804-8D86-E6E666C41E32 Q30239853-4D3E99E5-A43A-4DF1-B6C1-2DF2DFB6504D Q30251867-A69143F7-C172-4B00-BA94-AF90A5CA0F15 Q30319078-5547E7FB-2240-4676-B076-718C59C8ABB4 Q30371026-6B59D88B-A6C3-4F19-B32D-DAA13CDD4EED Q30417079-B38D069F-0F7F-471E-B81C-AEC849B40962 Q30687588-AE8E971F-AC64-487D-8943-7F7D35690018 Q30910604-95BA61C7-A37B-46F5-B662-F91B76BEF36F Q31164040-835B33C4-DF26-436C-8EEB-F8E202373EF5 Q33396480-4010130A-E2E6-4726-9673-C661F3DF4DDB Q33437306-E86CD277-4E26-4F54-9EFE-08C6559EE4BE Q33642414-B6B7E34C-6DA9-4D16-90D0-9819D9D69FA7 Q33649631-C1539066-F66F-4033-8C3B-7E2C5BFE65D6 Q33661362-19DEAD5E-8CB7-43CD-970A-74BCD441C029 Q33739346-7F32EFAD-F204-49BE-9EF1-C7A3386B656E Q33776103-5A8AF55E-8E05-4E52-B4C7-118CD13E4D27 Q33786331-3D9A3A50-8F19-4D28-954B-42A3364C9696 Q33791885-E7E30CA0-7670-45A5-AA2F-B4E1669FAA0D Q33848041-6CEC2B8B-F74C-464D-9779-06F61545FBDB Q33882962-C98E4ECD-20D3-471A-8FDF-1046E9BFB0C6 Q33936124-5264AAE5-01CB-412D-B688-A59109F87A43 Q33994074-A4BB27C2-E45C-4420-B7B7-0C2FFBE5275A Q34002205-BB44FA1A-035D-4A35-B82D-E40BFB7DDEDA Q34024602-DD66151C-910E-49AF-98ED-1867F4D5A228 Q34084527-98C919D6-590C-41FD-8DFC-7E21BC964E0F

P2860

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

http://www.wikidata.org/entity/Q36942534

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Outcomes associated with drug- ...... orative network meta-analysis.

@en

type

label

Outcomes associated with drug- ...... orative network meta-analysis.

@en

prefLabel

Outcomes associated with drug- ...... orative network meta-analysis.

@en

P1433

Q36942534-6E9A9912-37E2-4CDD-A0AD-B15B4E29E212

P1476

Q36942534-F7C62D0B-8197-4E49-B2FD-E160E3CDDDA7

P2093

Q36942534-020A78D9-4606-4BB5-AF00-A1962C12B45F

Q36942534-03EB8C87-AF74-46EE-829A-6E42BAD801A3

Q36942534-0E42731F-3D66-4626-BEE5-6CA0F576E262

Q36942534-13A23B38-0DF3-4F58-8135-72C62177CCA7

Q36942534-1437DC62-8770-4717-A185-2981E8FE8C22

Q36942534-1A9ED705-4057-4AB2-A500-30F9F2B31005

Q36942534-1CA7FF44-8D44-4FC9-A59D-769E04C041BA

Q36942534-20683467-26E3-415E-80F8-1D8B8B82F66D

Q36942534-35B362CD-ECC9-47D7-B366-6DED68C84740

Q36942534-3BB2D890-94C7-4951-A07B-A1F64DCFDDE5

P304

Q36942534-DD99059E-3220-49D8-B818-3DBBAA572632

P31

Q36942534-75d49ca7-a570-4c53-bfae-bbc7fd020966

Q36942534-9A219E2F-0BEC-44ED-AEC9-4C4415A93858

P356

Q36942534-F4BB4FFE-F42A-4AF7-BC38-94A25A306DE9

P407

Q36942534-A51481B2-ABEC-4F6D-B9CA-5FEAC8816990

P433

Q36942534-0EBD6D0A-1EEE-4284-ABBB-81E2672842A8

P478

Q36942534-A3C13517-A4D2-4723-82C0-0682FD444A5C

P50

Q36942534-63B01CF0-9D71-4552-8189-778EDE5C423F

Q36942534-6D0F9E4E-A039-420F-BA94-0EE10DCC6C45

Q36942534-6DC996A2-721F-4C1E-8A74-381D300661A6

Q36942534-DDBA5947-1CAE-443A-9608-5DCE9C4A1B5E

Q36942534-E5A8C21D-8658-404B-B7B3-1FA7B076CE7F

P577

Q36942534-AE39516C-72DB-4371-AD3F-2B21C80BEE55

P5875

Q36942534-8F9B63E1-B562-4AE1-BD52-39C5638247DC

P698

Q36942534-6C82EDD8-34E5-46D0-BBD9-4463E749F401

P921

Q36942534-AB90A1B1-20C6-42A1-81C3-FBE7A58A13E4

P356

S0140-6736(07)61444-5

P1433

P1476

Outcomes associated with drug- ...... orative network meta-analysis.

@en

P2093

Alain J Nordmann

http://www.w3.org/2001/XMLSchema#string

Anna Sonia Petronio

http://www.w3.org/2001/XMLSchema#string

Bernhard Meier

http://www.w3.org/2001/XMLSchema#string

Christian Spaulding

http://www.w3.org/2001/XMLSchema#string

Christoph Stettler

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Henning Kelbaek

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Goy

http://www.w3.org/2001/XMLSchema#string

José Suarez de Lezo

http://www.w3.org/2001/XMLSchema#string

Maarten J Suttorp

http://www.w3.org/2001/XMLSchema#string

P304

937-948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(07)61444-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

9591

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P50

Stephan Reichenbach

Albert Schömig

Stephan Windecker

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5970781

http://www.w3.org/2001/XMLSchema#string

P698

17869634

http://www.w3.org/2001/XMLSchema#string

P921